AI-generated summary
In this randomized controlled trial of 29 breast cancer patients receiving taxane chemotherapy, the authors report that adding photobiomodulation to scalp cooling did not significantly change scalp coverage or hair thickness compared with the control group. The photobiomodulation group scored higher on several quality-of-life measures, and the authors call for further research.
- Participants
- 29
- Who or what was studied
- Breast cancer patients undergoing taxane-based chemotherapy at Jessa Hospital, Belgium
- Limits stated in the abstract
- The abstract reports a small sample split into two groups of 16 and 13 patients, and the authors themselves say further research is needed to corroborate the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Photobiomodulation therapy, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.